Femtobiomed (XKRX:327610) Days Payable : 13.82 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Days Payable?

Femtobiomed's average Accounts Payable for the six months ended in Dec. 2023 was ₩4.8 Mil. Femtobiomed's Cost of Goods Sold for the six months ended in Dec. 2023 was ₩125.4 Mil. Hence, Femtobiomed's Days Payable for the six months ended in Dec. 2023 was 6.91.

The historical rank and industry rank for Femtobiomed's Days Payable or its related term are showing as below:

XKRX:327610' s Days Payable Range Over the Past 10 Years
Min: 1.2 Med: 3.2 Max: 13.82
Current: 13.82

During the past 6 years, Femtobiomed's highest Days Payable was 13.82. The lowest was 1.20. And the median was 3.20.

XKRX:327610's Days Payable is ranked worse than
94.17% of 720 companies
in the Biotechnology industry
Industry Median: 148.53 vs XKRX:327610: 13.82

Femtobiomed's Days Payable increased from Dec. 2021 (0.00) to Dec. 2023 (13.82). It may suggest that Femtobiomed delayed paying its suppliers.

Femtobiomed Days Payable Historical Data

The historical data trend for Femtobiomed's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed Days Payable Chart

Femtobiomed Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

3.20

1.20

13.82

Femtobiomed Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Days Payable	Get a 7-Day Free Trial			3.20	1.20	-	-	13.82

Competitive Comparison of Femtobiomed's Days Payable

For the Biotechnology subindustry, Femtobiomed's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Femtobiomed's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Femtobiomed's Days Payable distribution charts can be found below:

* The bar in red indicates where Femtobiomed's Days Payable falls into.

Femtobiomed Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Femtobiomed's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	4.75)	/	1 )	/	125.449	*	365
=	4.75					/	125.449	*	365
=	13.82

Femtobiomed's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	4.75)	/	1 )	/	125.449	*	365 / 2
=	4.75					/	125.449	*	365 / 2
=	6.91

Femtobiomed Days Payable Related Terms

Thank you for viewing the detailed overview of Femtobiomed's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Femtobiomed (XKRX:327610) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487

Website

https://www.femtobiomed.com

Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed (XKRX:327610) Headlines

No Headlines